how safe are glp-1 medications The first ever FDA-approved pill for weight loss. Now on Ro. For Important Safety Information about GLP-1 medications, including Boxed Warning, go to ro.co/safety #wegovy #glp1 Ten Top Tips for the

Pharmacists play a central role in monitoring, counseling on, and facilitating access to GLP-1 RAs, thereby supporting optimal clinical outcomes and therapy tolerability

Subcutaneous injections deliver the drug directly into the bloodstream, ensuring immediate bioavailability, whereas transdermal patches continuously deliver the drug through the skin

Key findings relevant to injection site safety: Injection site reactions were not significantly higher in retatrutide groups compared to placebo The most common injection site reactions were transient redness and mild discomfort No participants discontinued due to injection site reactions The overall safety profile was consistent with other GLP-1 receptor agonists The more recent TRIUMPH-4 phase 3 trial confirmed these safety findings in a larger population

Published in the Lancet Psychiatry, the research also examined data on new diagnoses of anxiety and depression

Current access is limited to clinical trials and research peptide suppliers

Diarrhea (the second most commonly reported side effect) Avoid greasy or spicy foods and limit caffeine and alcohol